Mortality Risk in Oropharynx Cancer Varies Based on HPV Status
Patients with OPC with HPV-negative tumors have increased risk for head and neck cancer mortality.
Head and Neck Cancer
Head & Neck Cancer News & Features
Routine HPV Testing May Be Warranted for Sinonasal Cancers
HPV-positive sinonasal squamous cell carcinoma associated with improved overall survival.
Endoscopic Approaches Feasible in Surgery for Sinonasal Cancer
Overall, 87.4 percent of 239 patients achieved negative margins with endoscopic resection.
U.S. Incidence of Thyroid Cancer Plateaued in 2009
Significant slowing found in rate of increase from 2009 to 2014, followed by stable rate since 2014.
Initial Therapy of Advanced Anaplastic Thyroid Cancer via Targeting VEGFR-2: A Case Report
[OncoTargets and Therapy] Researchers outline the case of a 93-year-old female with advanced ATC who received initial treatment with apatinib.
Strategies for Managing Postradiotherapy Cerebral Radiation Necrosis in Nontarget Brain Tissue
This review seeks to shed light on a relatively common but poorly understood adverse effect of radiotherapy for primary and metastatic brain or head and neck tumors.
Pembrolizumab Prolongs Survival in Advanced Head, Neck Cancer
Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment.
The Disappointing Reality of Crowdfunding Cancer Care
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
Incidence of HPV-Positive Head and Neck Cancer Up in the U.S.
From 2013 to 2014, incidence of HPV-positive oropharyngeal cancers was 4.62 per 100,000 persons.
Want to read more?
Please login or register first to view this content.
Next post in Head and Neck Cancer
